American Business Council Nigeria

The Multiple Myeloma Research Foundation (MMRF) Names Stephanie Oestreich, Ph.D., MPA, as Managing Director of the Myeloma Investment Fund (MIF)

Retrieved on: 
木曜日, 10月 5, 2023
Biotechnology, Health, Other Health, Pharmaceutical, Other Philanthropy, Philanthropy, Oncology, Other Science, Research, General Health, Fund Raising, Health Technology, Foundation, Science, RA, John F. Kennedy High School, Faculty, Business, Drug development, ARCH Venture Partners, Multiple myeloma, Multiple Myeloma Research Foundation, Harvard University, Novartis, American Business Council Nigeria, Arm, Galecto Biotech, Therapy, W20, MMRF, MIT, G20, MPA, Growth, CART, Evotec, Business development, Commercial, Patient, Management, Bruker

The Multiple Myeloma Research Foundation (MMRF) has announced the appointment of Stephanie Oestreich, Ph.D., MPA, as Managing Director of its venture philanthropy subsidiary, the Myeloma Investment Fund (MIF).

Key Points: 
  • The Multiple Myeloma Research Foundation (MMRF) has announced the appointment of Stephanie Oestreich, Ph.D., MPA, as Managing Director of its venture philanthropy subsidiary, the Myeloma Investment Fund (MIF).
  • In this role, Dr. Oestreich will lead the overall execution of the MIF’s investment strategy and serve as a member of the MMRF executive leadership team.
  • “We are thrilled to have Dr. Oestreich join our team as Managing Director of the MIF,” said Michael Andreini, President and CEO, the MMRF.
  • “The MIF invests in the most promising companies that are developing innovative clinical assets and technologies that could be transformative for myeloma patients.

Automation Workz Launches Employer Workforce Survey to Collect West Michigan Triangle Region Data to Accelerate Receipt of Federal Grants

Retrieved on: 
火曜日, 7月 25, 2023
Executive search, Society, University, NABJ, SHRM, Jack Welch Management Institute, Strayer University, MBA, Multimedia, Person, Economics, American Business Council Nigeria, ATD, Detroit Region Aerotropolis, Diversity, Invisibility, Book, AIAG, Management, Visa

https://www.surveymonkey.com/r/K9HLRLL Forward this survey to anyone who is a CEO, HR or Diversity professional.

Key Points: 
  • https://www.surveymonkey.com/r/K9HLRLL Forward this survey to anyone who is a CEO, HR or Diversity professional.
  • Ida Byrd-Hill is a graduate of the University of Michigan - Ann Arbor with a BA, Economics and Jack Welch Management Institute at Strayer University with an MBA.
  • She is plowing her expertise into the workforce pipeline, having educated 15,546 persons, in STEM.
  • Ida is the author of 8 books, including Invisible Talent Market-Solving the Talent Shortage Without Outsourcing and Visas.

Emergex Appoints Sir Michael Rake as Board Chairman

Retrieved on: 
木曜日, 6月 29, 2023
Private equity, FIS, KPMG, Employment, Royal National Institute of Blind People, House, Commerce, UK International Airlines, Sun, Infection, Former, Reputation, Child, Growth, Worldpay, Inc., Hospital, Great Ormond Street Hospital, RNIB, Pembroke College, EasyJet, Emperor, COVID-19, Trust, Title, Barclays, UK Commission for Employment and Skills, American Business Council Nigeria, CBI, Partnership, ICAEW, Lead, S&P Global, Commission, Senior advisor, S, FTSE, Elliott School of International Affairs, Vaccine, Management, Citibank

ABINGDON, United Kingdom, June 29, 2023 (GLOBE NEWSWIRE) -- Emergex Vaccines Holding Limited (‘Emergex’), a clinical-stage biotechnology company addressing major global infectious diseases through the development of fully synthetic T cell-priming immune set-point candidates, today announced the appointment of Sir Michael Rake as Chairman of the Board.

Key Points: 
  • ABINGDON, United Kingdom, June 29, 2023 (GLOBE NEWSWIRE) -- Emergex Vaccines Holding Limited (‘Emergex’), a clinical-stage biotechnology company addressing major global infectious diseases through the development of fully synthetic T cell-priming immune set-point candidates, today announced the appointment of Sir Michael Rake as Chairman of the Board.
  • Sir Michael takes on this role from Finian Tan, Ph.D., who becomes Emergex’s Deputy Chairman.
  • Sir Michael has had a long and distinguished career in international business as a Senior Executive and Board leader over several decades.
  • Sir Michael Rake, the new Chairman at Emergex, commented: “I look forward to joining the Emergex Board as Chairman and sharing my experience and network to help grow the business at such a pivotal time in the company’s evolution.